Clinical trials
Surveillance clinical trials
Below are recruiting surveillance clinical trials, each written for real people, not researchers. We’re tracking 310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03933670RecruitingPhase 2
MRI scan with special sugar to monitor prostate cancer on surveillance
This study uses a special MRI scan using “hyperpolarized” labeled pyruvate (a sugar-like substance) to see how prostate cancer may be behaving in people who are on active surveillance. It may help researchers monitor cancer without immediate treatment, by spotting changes earlier.
San Francisco, CaliforniaAges 18 years+ - NCT03729115Recruiting
Enhanced breast cancer screening for high-risk women
This study tests a more thorough breast cancer screening program using MRI and other imaging for women at high risk. It aims to detect cancer earlier, which may improve treatment options and outcomes.
La Jolla, CaliforniaAges 25 years+ - NCT03769766RecruitingPhase 3
Curcumin to help keep low-risk prostate cancer from worsening
This study tests whether curcumin (a supplement made from turmeric) can prevent low-risk prostate cancer from progressing while you stay on active surveillance. If you qualify, you would take curcumin and be monitored closely with regular checkups.
Dallas, TexasAges 40–89 - NCT03536312Recruiting
Surgery versus monitoring for enlarged ascending aorta
This trial compares two ways to treat an enlarged (bigger) ascending aorta: having surgery now versus careful imaging follow-up (surveillance). It may help you and your care team decide which approach lowers the risk of serious problems for aneurysms in a specific size range.
San Francisco, CaliforniaAges 18–79 - NCT03594630RecruitingEarly Phase 1
Watchful waiting then chemotherapy before surgery for rectal cancer
This trial studies whether a period of active surveillance (watching closely) and chemotherapy before surgery can improve outcomes for people with stage II–III rectal cancer. You would also receive standard chemo-radiation if you qualify, then proceed to surgery.
Houston, TexasAges 18 years+ - NCT03648359Enrolling by invitation
MRI scans to monitor low-risk prostate cancer in active surveillance
This trial uses special MRI scans to help track low-risk prostate cancer while you stay on active surveillance (meaning no immediate treatment). It may help your care team better understand changes in the cancer over time.
HerlevAges 18–75 - NCT03067181RecruitingPhase 3
Active surveillance and chemotherapy for germ cell tumors
This study looks at how to manage germ cell tumors in children and young adults using careful monitoring for some patients and chemotherapy for others. It aims to see whether these approaches can control the cancer while avoiding unnecessary treatment when possible.
Birmingham, AlabamaAges Any age - NCT03167203Enrolling by invitationPhase 1/Phase 2
Safety check after stem-cell eye treatment
This study follows people who previously received an embryonic stem-cell–derived treatment for macular (central) vision loss. Its goal is to watch for long-term side effects and better understand how safe the treatment is over time.
Kansas City, MissouriAges 18 years+ - NCT03193515Recruiting
Blood test to monitor bladder cancer returning
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
Los Angeles, CaliforniaAges 18 years+ - NCT02748408Recruiting
Long-term follow-up after total hip replacement for severe hip pain
This study tracks people for many years after they get their first total hip replacement due to severe hip problems. It helps doctors understand how well the implant works and how patients recover over time.
ViennaAges 18–75 - NCT02988128Recruiting
Medical device registry for Medtronic neurovascular products
This study follows people who receive a specific Medtronic neurovascular device to learn about safety and performance over time. It may help improve how these devices are used and monitored in real-world care.
Buenos AiresAges 18 years+ - NCT02732171Recruiting
Blood and bone marrow tests to track breast cancer return
This trial checks whether specific “surveillance” markers (measured from blood and bone marrow) can help predict if breast cancer comes back after standard treatments. It may help doctors monitor you more accurately and earlier if recurrence risk is high.
Philadelphia, PennsylvaniaAges 18 years+ - NCT02743858Recruiting
Watch swelling study after breast lymph node surgery
This study looks at how and when swelling (lymphedema) happens after breast cancer surgery on the armpit lymph nodes. You may be followed closely after your planned one-sided procedure to better understand who gets swelling and how it changes over time.
Basking Ridge, New JerseyAges 18 years+ - NCT02346435Recruiting
Watch small kidney growths, with added follow-up later
This registry follows people who have a small kidney mass found by chance on recent scans. It helps doctors understand the best timing for monitoring and possible treatment, to improve safety and outcomes.
Baltimore, MarylandAges 18–100 - NCT02526797Enrolling by invitation
MRI scan study for men on active surveillance
This trial tests how a special MRI scan (with multiple measurements) may help men with low-risk prostate cancer who are monitoring it closely instead of treating right away. It may help doctors better understand the cancer’s status during active surveillance.
HerlevAges 18–75 - NCT01511393Enrolling by invitation
Tracking people with thyroid cancer to learn its course
This study follows adults who have medullary thyroid cancer (MTC) to learn how the cancer behaves over time. It may help by improving future care and follow-up strategies for people with MTC.
Morgantown, West VirginiaAges 18 years+ - NCT01524276Recruiting
Registry to track outcomes of Medtronic medical devices
This is a follow-up registry that collects information from people who have (or will receive) an eligible Medtronic device. It helps the company and doctors better understand how the device works in real-world use.
Birmingham, AlabamaAges Any age - NCT02000687Recruiting
Long-term follow-up after islet transplant graft failure
This study follows people over the long term after their islet transplant fully stops working. It aims to learn what happens after complete graft loss and monitor health outcomes over time.
Miami, FloridaAges 18–75 - NCT00414115Recruiting
Studying side effects of medicines in children
This study follows children who take medicines to better understand what causes side effects. It also looks at family history and genetics to see who may be more likely to have an adverse reaction, and it checks findings using adults.
Vancouver, British ColumbiaAges Any age - NCT00599092Recruiting
Pituitary tumor follow-up for people with confirmed pituitary disease
This study focuses on people who already have a confirmed pituitary condition and will look at how tumor findings match with patient results over time. It may help improve how pituitary tumors are monitored and understood.
Los Angeles, CaliforniaAges 18 years+ - NCT00260585Recruiting
Esophageal risk and tissue registry study
This study collects information and, if you already need blood tests or procedures, may take extra small tissue samples (biopsies) to better understand esophageal-related conditions. It may help researchers learn about risk and future management for people with certain esophagus or reflux-related diagnoses.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT00756665Recruiting
Study of careful monitoring for prostate cancer
This study follows people with early-stage prostate cancer who choose active surveillance instead of immediate treatment. It aims to see how monitoring with repeat prostate biopsies and follow-up works over time.
San Francisco, CaliforniaAges 21 years+
Hear when a new Surveillance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for surveillance?
- Yes. Clin2 currently lists 310 recruiting surveillance studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a surveillance trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a surveillance trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.